Digestive & Intestinal Remedies (Pharmacies) - Rwanda

  • Rwanda
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$1.61m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 4.22%, resulting in a market volume of US$1.98m by 2029.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.11 are generated in 2024.

Key regions: Australia, United States, India, Europe, China

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Rwanda is experiencing significant growth and development.

Customer preferences:
Customers in Rwanda are increasingly seeking out digestive and intestinal remedies to address common gastrointestinal issues. This can be attributed to a variety of factors, including changes in diet and lifestyle, as well as an increased awareness of the importance of digestive health. As a result, there is a growing demand for products that can provide relief from digestive discomfort and promote overall gut health.

Trends in the market:
One of the key trends in the Digestive & Intestinal Remedies market in Rwanda is the increasing popularity of natural and herbal remedies. Customers are becoming more conscious of the potential side effects of traditional pharmaceutical products and are seeking out natural alternatives. This trend is driven by a desire for safer and more sustainable options, as well as a growing interest in traditional medicine practices. As a result, there has been a surge in the availability and sales of natural digestive remedies in pharmacies across the country. Another trend in the market is the rise of probiotics and prebiotics. Probiotics are live bacteria and yeasts that are beneficial to digestive health, while prebiotics are non-digestible fibers that promote the growth of beneficial bacteria in the gut. These products have gained popularity due to their ability to support a healthy gut microbiome and improve digestion. As a result, there has been an increase in the availability and variety of probiotic and prebiotic supplements in pharmacies in Rwanda.

Local special circumstances:
Rwanda has made significant progress in improving its healthcare system in recent years. The government has invested in expanding access to healthcare services, including pharmacies, in both urban and rural areas. This has resulted in an increase in the number of pharmacies in the country, making digestive and intestinal remedies more accessible to the population. Additionally, the government has implemented regulations to ensure the quality and safety of pharmaceutical products, further boosting consumer confidence in the market.

Underlying macroeconomic factors:
Rwanda has experienced steady economic growth in recent years, which has contributed to an increase in disposable income and improved living standards. As a result, consumers have more purchasing power and are willing to spend on products that support their health and well-being. This has created a favorable market environment for the Digestive & Intestinal Remedies market in Rwanda, as customers are more willing to invest in products that can improve their digestive health. In conclusion, the Digestive & Intestinal Remedies market in Rwanda is witnessing growth and development driven by customer preferences for natural and herbal remedies, as well as the popularity of probiotics and prebiotics. The government's efforts to improve healthcare infrastructure and regulate the pharmaceutical industry have also contributed to the market's growth. With a growing economy and increased consumer spending power, the market is expected to continue its upward trajectory in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)